Core Heavyweights
BPC-157 is a synthetic pentadecapeptide sequence derived from a protein found in gastric juice. It is one of the most widely studied research peptides in tissue repair and angiogenesis literature.
The counter-ion changes stability, not the peptide sequence. Arginate salt shows improved stability in solution and is generally preferred for oral and extended-storage research; acetate salt is the traditional lyophilized injectable research form.
Published literature describes BPC-157 acting through the VEGFR2-Akt-eNOS pathway, upregulating growth hormone receptor expression in fibroblasts and promoting angiogenesis at injury sites.
A 10mg vial with 2mL bacteriostatic water gives 5mg/mL. A 5mg vial with 2mL gives 2.5mg/mL. Keep reconstituted material refrigerated and use within the stability window on the COA.
Convert vial strength and bacteriostatic water volume into exact insulin-syringe unit marks.
Peptide reconstitution calculator
Concentration
5 mg/mL
Draw volume
0.05 mL
Insulin syringe
5 units (IU)
U-100 insulin syringe (100 units = 1 mL)
10 mg + 2 mL = 5 mg/mL. A 250 mcg dose = 5 units on a U-100 syringe (40 doses per vial).
For laboratory and research use only. Not for human or veterinary use.
Need solvent? Buy bacteriostatic water (10mL / 30mL)
Arginate salt is more stable in aqueous and gastric environments, which is why it is favoured for oral research formats. The peptide sequence is identical.
Every BPC-157 lot is released at 99%+ HPLC purity with a published, lot-matched certificate of analysis.
